Skip to main content
Caplight Logo









CheckEye

CheckEye

Private
KyivHealthcare & Life Scienceshttps://check-eye.com/

Last Round

Grant

May 1, 2025

Total Funding Raised

$125,000

Company Overview

CheckEye is a healthtech company that provides an AI-driven platform for the early detection and screening of chronic diseases, such as diabetic retinopathy, using retinal imaging.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Computer Vision, Healthcare Analytics

Business Model

B2B2C

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

diabetic retinopathy screeningretinal imagingsoftware as a medical deviceSaMDretinal screeningfundus image analysisAI diagnosticsmedical AItele-ophthalmologyremote eye screeningchronic disease screeningeye health AIAI eye examclinical decision supporthealthcare SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CheckEye Comparables

Compare CheckEye with similar companies based on industry and business-model similarity.

CheckEye comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Eyenuk
88%
AEYE Health
84%
RetinaLyze System A/S
83%

CheckEye Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 1, 2025
AngelFeb 1, 2025
GrantJun 20, 2024

Key People

Founding team and executive leadership

Kirill Goncharuk

CEO and Founder

Founding Team

CheckEye Investors

Notable investors and investment history

CheckEye investors
InvestorRounds
Ukraine-Moldova American Enterprise FundGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 18, 2026

    Monthly visitors increased 102% MoM, reaching 2.4K.

  • Feb 22, 2026

    Grew 23% QoQ from 13 to 16 employees.

CheckEye Filings

Explore SEC and related filing metadata, where available.

CheckEye filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CheckEye's valuation, stock price, and market status.

Is CheckEye a public or private company?

CheckEye is a private company.

What is the current stock price of CheckEye?

CheckEye is a private company with no public stock price. No recent secondary market data is available.

How much is CheckEye worth (valuation)?

Valuation information for CheckEye is not publicly available.

Can I buy CheckEye stock?

CheckEye shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CheckEye's last funding round?

CheckEye's most recent funding round was Grant on May 1, 2025.

Who are the main investors in CheckEye?

Key investors in CheckEye include Ukraine-Moldova American Enterprise Fund.

Will CheckEye IPO soon?

No public IPO plans have been announced for CheckEye.

How can I track CheckEye secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CheckEye's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersKyiv
Employee Range11
Year Founded2022
Last FundingMay 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?